SeaStar Medical Holding Corporation (NASDAQ:ICU) Sees Significant Increase in Short Interest

SeaStar Medical Holding Corporation (NASDAQ:ICU) was the recipient of a significant growth in short interest during the month of February. As of February 13th, there was short interest totaling 286,335 shares, a growth of 85.5% from the January 29th total of 154,400 shares. Currently, 7.6% of the shares of the stock are sold short. Based on an average trading volume of 108,978 shares, the short-interest ratio is currently 2.6 days. Based on an average trading volume of 108,978 shares, the short-interest ratio is currently 2.6 days. Currently, 7.6% of the shares of the stock are sold short.

SeaStar Medical Stock Up 0.7%

NASDAQ:ICU traded up $0.02 on Friday, reaching $2.76. The company’s stock had a trading volume of 79,738 shares, compared to its average volume of 84,124. SeaStar Medical has a 12-month low of $2.20 and a 12-month high of $25.70. The stock has a 50 day moving average price of $2.46 and a 200 day moving average price of $4.85. The firm has a market cap of $10.46 million, a price-to-earnings ratio of -0.17 and a beta of -1.00.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Maxim Group set a $6.00 price objective on SeaStar Medical in a research note on Thursday, February 12th. Wall Street Zen upgraded shares of SeaStar Medical to a “hold” rating in a research report on Saturday, January 10th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of SeaStar Medical in a research note on Thursday, January 22nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell” and a consensus target price of $6.00.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. XTX Topco Ltd raised its stake in shares of SeaStar Medical by 395.4% in the 2nd quarter. XTX Topco Ltd now owns 60,983 shares of the company’s stock valued at $26,000 after acquiring an additional 48,674 shares during the period. Trinity Financial Advisors LLC grew its stake in shares of SeaStar Medical by 233.3% in the third quarter. Trinity Financial Advisors LLC now owns 50,000 shares of the company’s stock valued at $28,000 after buying an additional 35,000 shares in the last quarter. Jane Street Group LLC purchased a new stake in shares of SeaStar Medical in the 4th quarter valued at $30,000. Finally, Millennium Management LLC acquired a new position in SeaStar Medical during the 3rd quarter worth about $102,000. Hedge funds and other institutional investors own 1.69% of the company’s stock.

About SeaStar Medical

SeaStar Medical, Inc (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies.

The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR.